|
Volumn 26, Issue 6, 2011, Pages 357-360
|
Reflux of drug during intra-vitreal anti-VEGF therapies
|
Author keywords
Avastin; Bevazicumab; Dosage; Injection; Ranibizumab; Reflux; Vitreous
|
Indexed keywords
BEVACIZUMAB;
RANIBIZUMAB;
ADULT;
AGED;
APPLICATION SITE SWELLING;
ARTICLE;
CONJUNCTIVA;
CONTROLLED STUDY;
EXUDATIVE MACULAR DEGENERATION;
EYE DISEASE;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD REVIEW;
NEOVASCULAR GLAUCOMA;
PHAKIC INTRAOCULAR LENS;
PRIORITY JOURNAL;
RETINA BLOOD VESSEL OCCLUSION;
RETINA MACULA AGE RELATED DEGENERATION;
RETINA MACULA CYSTOID EDEMA;
RETINA NEOVASCULARIZATION;
SUBCONJUNCTIVAL BLEB;
VITREOUS BODY DETACHMENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
BIOLOGICAL AVAILABILITY;
FEMALE;
HUMANS;
INTRAVITREAL INJECTIONS;
MALE;
MIDDLE AGED;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VITREOUS BODY;
WET MACULAR DEGENERATION;
|
EID: 80455168302
PISSN: 08820538
EISSN: 17445205
Source Type: Journal
DOI: 10.3109/08820538.2011.588648 Document Type: Article |
Times cited : (13)
|
References (6)
|